New Trial of Promising Lupus Treatment RSLV-132 Has Finished Enrolling Patients
July 30, 2019
Resolve Therapeutics announced that it has enrolled enough patients to conduct a Phase 2a study of a...
Dr. Keith Elkon
LRA Grant Leads to New Drug Candidate RSLV-132
May 10, 2019
Grant support from the Lupus Research Alliance (then ALR) supported early work that led to a potential...
Lupus Research Alliance Announces Translational Research Grants to Speed Development of New Treatments
NEW YORK, NY – January 10. Can “borrowed” drugs for treating other diseases protect the skin in patients with...
Scientists Focus on Innate Immune System as Possible Lupus Treatment Approach
January 7, 2019
The 2018 Forum for Discovery opened with a series of lectures on new research on the role of...